Opko Health, Inc.
OPK
$1.38
-$0.02-1.43%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 156.81M | 149.95M | 183.64M | 173.63M | 182.19M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 156.81M | 149.95M | 183.64M | 173.63M | 182.19M |
Cost of Revenue | 137.75M | 138.17M | 129.40M | 162.27M | 154.62M |
Gross Profit | 19.06M | 11.78M | 54.23M | 11.36M | 27.57M |
SG&A Expenses | 59.60M | 59.09M | 67.03M | 98.20M | 68.82M |
Depreciation & Amortization | 19.44M | 19.86M | 20.34M | 20.43M | 20.42M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 216.79M | 217.12M | 216.78M | 280.91M | 243.86M |
Operating Income | -59.98M | -67.17M | -33.14M | -107.28M | -61.67M |
Income Before Tax | -162.52M | -73.38M | 34.97M | 48.42M | -10.59M |
Income Tax Expenses | -14.08M | -5.77M | 20.95M | 23.53M | -280.00K |
Earnings from Continuing Operations | -148.44M | -67.61M | 14.03M | 24.89M | -10.31M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -148.44M | -67.61M | 14.03M | 24.89M | -10.31M |
EBIT | -59.98M | -67.17M | -33.14M | -107.28M | -61.67M |
EBITDA | -36.95M | -43.68M | -9.10M | -83.11M | -37.52M |
EPS Basic | -0.19 | -0.10 | 0.02 | 0.04 | -0.01 |
Normalized Basic EPS | -0.13 | -0.07 | 0.13 | -0.11 | -0.01 |
EPS Diluted | -0.19 | -0.10 | 0.02 | 0.03 | -0.01 |
Normalized Diluted EPS | -0.13 | -0.07 | 0.09 | -0.07 | -0.01 |
Average Basic Shares Outstanding | 788.01M | 671.58M | 676.79M | 694.62M | 697.21M |
Average Diluted Shares Outstanding | 788.01M | 671.58M | 951.84M | 998.36M | 697.21M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |